Penem Antibacterial
40 drugs across 17 manufacturers|39 Generic,1 Brand
The Penem Antibacterial class contains 40 NDCs from 17 manufacturers (39 generic, 1 brand), at an average NADAC of $15.28 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
40
39G / 1B
Manufacturers
17
Avg $15.2790/unit
Avg 7d Change
-3.82%
Across 27 drugs with changes
7d Activity
of 40 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
17 manufacturers producing drugs in this therapeutic class(1 pricing outlier)
and 5 more manufacturers
Follow this class across the site
These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.
Top supplier
Hospira Inc. manufacturer profile
Review the supplier with the strongest product footprint inside this therapeutic class.
Lead market
Meropenem market page
Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.
Trend hub
Latest trend hub
Compare this class against the rest of the weekly NADAC trend surface.
Guide
Understanding NADAC pricing
Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.
Frequently Asked Questions
How many drugs are in the Penem Antibacterial class?
The Penem Antibacterial class contains 40 NDCs from 17 manufacturers — 39 generic and 1 brand product.
What is the average price of Penem Antibacterial drugs?
The average NADAC for the Penem Antibacterial class is $15.2790 per unit across 40 NDCs.
Is generic cheaper than brand in the Penem Antibacterial class?
Among products priced per EA, the average generic NADAC in this class is $12.5318, versus $122.4195 for brand — brand products average about 9.8× the generic price.
Which manufacturers make Penem Antibacterial drugs?
17 manufacturers make drugs in the Penem Antibacterial class. Ranked by number of NDCs, the largest are Hospira Inc. (5), WG Critical Care, LLC (5), Fresenius Kabi USA, LLC (5), Eugia US LLC (4), Hikma Pharmaceuticals USA Inc. (3).
How has Penem Antibacterial pricing changed recently?
Over the past 7 days, 13 NDCs in this class rose and 14 fell, with a class-wide average change of -3.8%.